Lpl Financial Lowered Core Laboratories N V (CLB) Stake; IBI Group Inc. (TSE:IBG) Had 0 Bulls

January 13, 2018 - By Marie Mckinney

Among 3 analysts covering IBI Group (TSE:IBG), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. IBI Group had 8 analyst reports since August 17, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Raymond James given on Tuesday, November 17. Raymond James downgraded IBI Group Inc. (TSE:IBG) rating on Friday, March 10. Raymond James has “Market Perform” rating and $6.50 target. As per Thursday, December 1, the company rating was maintained by Scotia Capital. Canaccord Genuity downgraded it to “Hold” rating and $5 target in Wednesday, June 15 report. See IBI Group Inc. (TSE:IBG) latest ratings:

Lpl Financial Llc decreased Core Laboratories N V (CLB) stake by 60.77% reported in 2017Q3 SEC filing. Lpl Financial Llc sold 3,481 shares as Core Laboratories N V (CLB)’s stock declined 4.78%. The Lpl Financial Llc holds 2,247 shares with $222,000 value, down from 5,728 last quarter. Core Laboratories N V now has $5.26 billion valuation. The stock increased 0.09% or $0.11 during the last trading session, reaching $119.1. About 318,286 shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 5.82% since January 13, 2017 and is downtrending. It has underperformed by 22.52% the S&P500.

Investors sentiment decreased to 1.07 in 2017 Q3. Its down 0.01, from 1.08 in 2017Q2. It dived, as 45 investors sold CLB shares while 99 reduced holdings. 42 funds opened positions while 112 raised stakes. 49.25 million shares or 6.07% more from 46.43 million shares in 2017Q2 were reported. Lenox Wealth Management Incorporated accumulated 0.01% or 281 shares. Neuberger Berman Grp Inc Ltd stated it has 0.03% in Core Laboratories N.V. (NYSE:CLB). Thompson Davis & invested in 0.05% or 267 shares. Florida-based Eagle Asset Mngmt Incorporated has invested 0.03% in Core Laboratories N.V. (NYSE:CLB). Halsey Associate Incorporated Ct stated it has 1.17% in Core Laboratories N.V. (NYSE:CLB). 43,430 are held by Great West Life Assurance Can. Cornerstone Advisors holds 0.1% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 1,543 shares. Michigan-based Telemus Ltd Llc has invested 0.42% in Core Laboratories N.V. (NYSE:CLB). Daiwa Securities Grp Incorporated holds 0% or 1,400 shares. Amp reported 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Rhumbline Advisers, a Massachusetts-based fund reported 43,262 shares. Moreover, Peoples Fincl Svcs Corporation has 0% invested in Core Laboratories N.V. (NYSE:CLB) for 42 shares. Ashford Capital Mgmt holds 18,150 shares or 0.29% of its portfolio. Clearbridge Ltd Limited Liability Company holds 0.49% or 5.19 million shares. Prudential Financial holds 25,941 shares or 0% of its portfolio.

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories had 51 analyst reports since August 24, 2015 according to SRatingsIntel. JP Morgan initiated Core Laboratories N.V. (NYSE:CLB) rating on Friday, June 10. JP Morgan has “Overweight” rating and $120 target. Cowen & Co maintained the shares of CLB in report on Monday, October 26 with “Market Perform” rating. The firm has “Neutral” rating by Citigroup given on Wednesday, September 28. Citigroup maintained it with “Neutral” rating and $100 target in Wednesday, July 26 report. The rating was maintained by Sterne Agee CRT on Wednesday, September 30 with “Neutral”. The stock has “Outperform” rating by RBC Capital Markets on Thursday, January 28. The rating was maintained by Cowen & Co with “Hold” on Friday, October 6. The company was initiated on Friday, March 24 by Tudor Pickering. UBS maintained Core Laboratories N.V. (NYSE:CLB) rating on Wednesday, October 25. UBS has “Neutral” rating and $100 target. On Friday, March 18 the stock rating was maintained by Citigroup with “Neutral”.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on January, 24. They expect $0.58 EPS, up 41.46% or $0.17 from last year’s $0.41 per share. CLB’s profit will be $25.61M for 51.34 P/E if the $0.58 EPS becomes a reality. After $0.48 actual EPS reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 20.83% EPS growth.

Lpl Financial Llc increased Spdr Index Shs Fds (FEZ) stake by 15,510 shares to 136,546 valued at $5.63 million in 2017Q3. It also upped Ishares Tr (IBMI) stake by 18,482 shares and now owns 73,295 shares. First Tr Sml Cp Core Alpha F (FYX) was raised too.

The stock increased 0.56% or $0.05 during the last trading session, reaching $8.98. About 27,492 shares traded or 6.12% up from the average. IBI Group Inc. (TSE:IBG) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

IBI Group Inc. provides various professional services in Canada, the United States, and internationally. The company has market cap of $336.50 million. The Company’s professional services include planning, design, implementation, analysis of operations, and other consulting services related to intelligence, buildings, and infrastructure areas. It has a 18.52 P/E ratio. The firm offers civic and government, healthcare, higher education, hospitality, justice and protective, K-12 education, mixed-use, residential, retail and commercial, senior communities, stadium and special event, and landscape architectural services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>